Want to see SG:H02 full AI Analyst Report?
H02 Stock Chart & Stats
S$16.18
-S$0.19(-1.17%)
At close: 4:00 PM EDT
S$16.18
-S$0.19(-1.17%)
Day’s Range― - ―
52-Week RangeS$13.80 - S$18.27
Previous CloseN/A
Volume164.30K
Average Volume (3M)144.52K
Market Cap
S$3.33B
Enterprise ValueS$2.68K
Total Cash (Recent Filing)S$881.34M
Total Debt (Recent Filing)S$52.60M
Price to Earnings (P/E)14.5
Beta0.73
Next Earnings
Feb 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.66%
Share Statistics
EPS (TTM)1.04
Shares Outstanding221,368,180
10 Day Avg. Volume160,760
30 Day Avg. Volume144,516
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)0.81
Price to Sales (P/S)15.10
P/FCF Ratio12.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.25
Revenue Forecast (FY)S$244.68M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthThe company's very conservative financing (debt-to-equity ~0.01) gives durable financial flexibility, allowing it to fund operations, pursue opportunistic investments or withstand downturns without refinancing stress. This structural strength supports steady capital allocation and risk management over months to years.
Strong 2025 Cash GenerationA material improvement in cash generation in 2025, with FCF nearly matching net income, indicates the business can convert earnings into real cash. Sustained cash conversion enhances capacity to fund dividends, reinvest in brands or properties, and reduces dependence on external financing over the medium term.
Established Brand And Diversified RevenuesStrong Tiger Balm brand and multiple income streams (OTC healthcare products, recurring property rental, leisure admissions, and investment income) create structural resilience. Diversification across product and asset classes reduces single-market dependence and supports more predictable cash flows over several quarters.
Bears Say
2025 Revenue DeclineA near-term top-line contraction (-9.12% in 2025) interrupts prior growth momentum and could weaken operating leverage. If the decline reflects structural demand shifts or distribution loss, it may constrain reinvestment, capex and long-term revenue visibility, reducing growth optionality over the next 2-6 months.
Earnings Quality ConcernsUnusually high reported net margins point to material non-operating or one-off gains influencing profitability. Reliance on fair-value or investment gains reduces repeatability of earnings and complicates forecasting core operating performance, weakening confidence in sustainable profit margins over time.
Lumpy Historical Cash ConversionPrior years showed weak cash conversion relative to accounting profits, indicating timing volatility and working capital sensitivity. Even with 2025 improvement, past lumpiness suggests cash flows can be unpredictable, complicating reliable capital allocation, dividend planning and near-term financial forecasting.
Haw Par News
H02 FAQ
What was Haw Par Corporation Limited’s price range in the past 12 months?
Haw Par Corporation Limited lowest share price was S$13.80 and its highest was S$18.27 in the past 12 months.
What is Haw Par Corporation Limited’s market cap?
Haw Par Corporation Limited’s market cap is S$3.33B.
When is Haw Par Corporation Limited’s upcoming earnings report date?
Haw Par Corporation Limited’s upcoming earnings report date is Feb 19, 2027 which is in 180 days.
How were Haw Par Corporation Limited’s earnings last quarter?
Haw Par Corporation Limited released its earnings results on Aug 14, 2026. The company reported S$0.487 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Haw Par Corporation Limited overvalued?
According to Wall Street analysts Haw Par Corporation Limited’s price is currently Overvalued.
Does Haw Par Corporation Limited pay dividends?
Haw Par Corporation Limited pays a Annually dividend of S$0.2 which represents an annual dividend yield of 2.66%. See more information on Haw Par Corporation Limited dividends here
What is Haw Par Corporation Limited’s EPS estimate?
Haw Par Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Haw Par Corporation Limited have?
Haw Par Corporation Limited has 221,368,180 shares outstanding.
What happened to Haw Par Corporation Limited’s price movement after its last earnings report?
Haw Par Corporation Limited reported an EPS of S$0.487 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.584%.
Which hedge fund is a major shareholder of Haw Par Corporation Limited?
Currently, no hedge funds are holding shares in SG:H02
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Haw Par Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.41%
12-Months-Change
Fundamentals
Return on Equity
2.66%
Trailing 12-Months
Asset Growth
14.13%
Trailing 12-Months
Company Description
Haw Par Corporation Limited
Established in Singapore in 1969, Haw Par Corporation Limited specializes in the manufacturing, marketing, and global trade of healthcare products, serving markets in Singapore, ASEAN countries, other Asian regions, and beyond. The company's business activities are structured into three main segments: Healthcare, Investments, and Others. Its Healthcare segment primarily produces and distributes topical pain relief solutions, prominently featuring the Tiger Balm and Kwan Loong brands. The Investments segment focuses on acquiring publicly traded securities. Additionally, Haw Par owns and leases out a diverse portfolio of investment properties, comprising 45,324 square meters of commercial and industrial real estate across Singapore and Malaysia. The corporation also offers family and tourist-oriented leisure experiences, notably through oceanariums. Furthermore, it provides leasing services for land, buildings, and office spaces, in addition to offering management support.
Technical Analysis
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
Hyphens Pharma International Ltd.
―
ISEC Healthcare Ltd
―
Medtecs International Corporation Ltd.
―



